Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 591 | 2,106 | 2,310 | 3,745 | 3,190 |
| Income taxes - deferred | N/A | N/A | N/A | 0 | -2,745 |
| Accounts receivable | -620 | 511 | -317 | -113 | 361 |
| Accounts payable and accrued liabilities | 6,299 | N/A | N/A | N/A | N/A |
| Other Working Capital | -104 | 4,081 | -1,230 | 5,920 | 2,283 |
| Other Operating Activity | -28,899 | -31,606 | -29,613 | -31,053 | -20,090 |
| Operating Cash Flow | $-22,733 | $-24,908 | $-28,850 | $-21,501 | $-17,001 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -324 | -59 | -375 | -2,207 |
| Net Acquisitions | N/A | N/A | N/A | 0 | -7,124 |
| Purchase Of Investment | -66,280 | N/A | N/A | -45,323 | N/A |
| Sale Of Investment | 30,797 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 10,452 | 22,549 | 0 | 0 |
| Investing Cash Flow | $-35,483 | $10,128 | $22,490 | $-45,698 | $-9,331 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 0 | -379 | -84 | -99 | -78 |
| Common Stock Issued | N/A | 8,511 | 0 | 49,865 | 267 |
| Other Financing Activity | 290,907 | 5,372 | 0 | -4 | 67 |
| Financing Cash Flow | $290,907 | $13,504 | $-84 | $49,761 | $256 |
| Exchange Rate Effect | 325 | 542 | 917 | -146 | -929 |
| Beginning Cash Position | 14,584 | 15,318 | 20,823 | 40,138 | 64,557 |
| End Cash Position | 247,600 | 14,584 | 15,295 | 22,553 | 37,551 |
| Net Cash Flow | $232,691 | $-1,276 | $-6,445 | $-17,438 | $-26,076 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,733 | -24,908 | -28,850 | -21,501 | -17,001 |
| Capital Expenditure | N/A | -324 | -59 | -375 | -2,207 |
| Free Cash Flow | -22,733 | -25,232 | -28,910 | -21,876 | -19,208 |